ARS Pharmaceuticals (SPRY) Inventory Average (2024 - 2026)

ARS Pharmaceuticals (SPRY) has 3 years of Inventory Average data on file, last reported at $8.6 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 37.69% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (up 37.69% YoY), and the FY2025 full-year result was $6.8 million, changed N/A from the prior year.
• Inventory Average grew to $8.6 million in Q1 2026, from $8.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $8.6 million in Q1 2026 to a low of $3.0 million in Q4 2024.
• A 3-year average of $7.0 million and a median of $8.0 million in 2025 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average soared 172.5% in 2025 and soared 37.69% in 2026, its largest moves.
• Tracing SPRY's Inventory Average over 3 years: stood at $3.0 million in 2024, then surged by 172.5% to $8.1 million in 2025, then advanced by 6.41% to $8.6 million in 2026.
• Business Quant data shows SPRY's Inventory Average at $8.6 million in Q1 2026, $8.1 million in Q4 2025, and $8.3 million in Q3 2025.